Author: Eka Paatashvili Over this last year, countries around the world have been forced to focus most of their efforts on fighting the COVID-19 pandemic, potentially leaving other health priorities, including routine immunization, to fall by the wayside. To understand…
Curatio International Foundation publishes the new 14th wave of the healthcare barometer which analyzes the financial situation and risks in Georgian healthcare sector.
The evidence review summarizes the existing literature on P4P effectiveness on utilization and quality of primary health care in private settings in middle-income and high- income countries. The document and its findings are especially relevant to Georgia.
The research project aims to understand what are the risks to quality and accessibility of patient care from excessive concentration and/or fragmentation in private healthcare markets, and what health system policies are available to address these?
As I embark on writing this blog, the global outbreak of COVID-19 is posing a growing threat to the health and well-being of our societies. The unfolding global health and economic crisis demands bold actions from all of us, but most importantly from policymakers.
The 42-month duration project “Prevention of Addiction and Mental Health in Adolescents in Georgia (PAMAd)” aims to improve the health and wellbeing of adolescents and young people affected by substance use and common mental health disorders through effective service provision.
The document emphasizes the role of Universal Health Care Program in increased access to health services, although it concludes that PHC needs prioritization and improved program management to address existing challenges in the system: fragmentation in service provision and inefficiency in service delivery.
Georgia has a high overall tuberculosis treatment success rate, but with wide geographical variation, and a high loss to follow up. Treatment success rate of drug-sensitive patients varies from 50% to 100%. Even more worrying has been the relatively low treatment success rates for multi-drug resistant TB patients, at around 56%.
The project aims to generate reliable information about MSM population size and define the population HIV and Hepatitis C risk behaviour. The results of the study will be used to assess the national response to HIV/AIDS and to plan the adequate national program.
They produce medicines that can save lives and at the same time artificially restrict access to these drugs for financially deprived people and for countries that fall outside their commercial interests.